Literature DB >> 10437687

Autosomal dominant non-syndromal low-frequency sensorineural hearing impairment linked to chromosome 4p16 (DFNA14): statistical analysis of hearing threshold in relation to age and evaluation of vestibulo-ocular functions.

H Kunst1, H Marres, P Huygen, G Van Camp, F Joosten, C Cremers.   

Abstract

A Dutch kindred was studied with low-frequency sensorineural hearing impairment linked to a new locus on chromosome 4p16 (DFNA14). Of the affected individuals, 21 (aged 11-75 years) were examined and the most recent audiogram was used for cross-sectional analysis of hearing threshold in relation to age. Suitable serial audiograms were available for a longitudinal analysis in nine cases: they had been obtained from the age of six years onwards and covered a follow-up period from 14 to 36 years. The presumably congenital (offset) component of SNHI was extrapolated or estimated from average values and offset thresholds were found of about 45 dB at 0.25-1 kHz, 25 dB at 2 kHz and 10 dB at 4-8 kHz. Significant progression in hearing impairment occurred at all frequencies, but could be attributed to presbyacusis. The combination of congenital, stationary low-frequency SNHI and presbyacusis resulted in an up-sloping audiogram in the first five decades of life, which evolved into a flat-type audiogram in the sixth or seventh decade and a down-sloping audiogram at a more advanced age. With few exceptions, vestibular function was intact.

Entities:  

Mesh:

Year:  1999        PMID: 10437687     DOI: 10.3109/00206099909073018

Source DB:  PubMed          Journal:  Audiology        ISSN: 0020-6091


  7 in total

1.  Mutations in the Wolfram syndrome 1 gene (WFS1) are a common cause of low frequency sensorineural hearing loss.

Authors:  I N Bespalova; G Van Camp; S J Bom; D J Brown; K Cryns; A T DeWan; A E Erson; K Flothmann; H P Kunst; P Kurnool; T A Sivakumaran; C W Cremers; S M Leal; M Burmeister; M M Lesperance
Journal:  Hum Mol Genet       Date:  2001-10-15       Impact factor: 6.150

2.  Mutations in the Wolfram syndrome type 1 gene (WFS1) define a clinical entity of dominant low-frequency sensorineural hearing loss.

Authors:  Marci M Lesperance; James W Hall; Theresa B San Agustin; Suzanne M Leal
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2003-04

3.  Mutations in PTPRQ are a cause of autosomal-recessive nonsyndromic hearing impairment DFNB84 and associated with vestibular dysfunction.

Authors:  Margit Schraders; Jaap Oostrik; Patrick L M Huygen; Tim M Strom; Erwin van Wijk; Henricus P M Kunst; Lies H Hoefsloot; Cor W R J Cremers; Ronald J C Admiraal; Hannie Kremer
Journal:  Am J Hum Genet       Date:  2010-03-25       Impact factor: 11.025

Review 4.  Vestibular function in families with inherited autosomal dominant hearing loss.

Authors:  Valerie A Street; Jeremy C Kallman; Paul D Strombom; Naomi F Bramhall; James O Phillips
Journal:  J Vestib Res       Date:  2008       Impact factor: 2.435

5.  Homozygosity mapping reveals mutations of GRXCR1 as a cause of autosomal-recessive nonsyndromic hearing impairment.

Authors:  Margit Schraders; Kwanghyuk Lee; Jaap Oostrik; Patrick L M Huygen; Ghazanfar Ali; Lies H Hoefsloot; Joris A Veltman; Frans P M Cremers; Sulman Basit; Muhammad Ansar; Cor W R J Cremers; Henricus P M Kunst; Wasim Ahmad; Ronald J C Admiraal; Suzanne M Leal; Hannie Kremer
Journal:  Am J Hum Genet       Date:  2010-02-04       Impact factor: 11.025

6.  Autosomal dominant optic neuropathy and sensorineual hearing loss associated with a novel mutation of WFS1.

Authors:  Barend F T Hogewind; Ronald J E Pennings; Frans A Hol; Henricus P M Kunst; Elisabeth H Hoefsloot; Johannes R M Cruysberg; Cor W R J Cremers
Journal:  Mol Vis       Date:  2010-01-12       Impact factor: 2.367

7.  A novel WFS1 mutation in a family with dominant low frequency sensorineural hearing loss with normal VEMP and EcochG findings.

Authors:  Naomi F Bramhall; Jeremy C Kallman; Aimee M Verrall; Valerie A Street
Journal:  BMC Med Genet       Date:  2008-06-02       Impact factor: 2.103

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.